|
⚲
|
| Keyboard |
| Moxie Dwight
✚
|
|
|---|---|
| CIK # | 0001803375 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001803375] | |
| 4 | [0001803375] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Revance Therapeutics Inc | |
| Moxie Dwight |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 95,979 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 18,125 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Grant | 18,125 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 47,815 | $3.65 | 174,525 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-03 | Grant | 5,979 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-03-18 | Sell | 8,125 | $5.04 | 40,950 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-03-15 | Tax withheld | 3,269 | $5.31 | 17,358 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-02-29 | Grant | 15,143 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Performance Stock Units · derivative
|
2024-01-31 | Grant | 135,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-01-31 | Grant | 90,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-09-06 | Sell | 11,000 | $17.06 | 187,660 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-09-05 | Sell | 23,853 | $17.81 | 424,822 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-08-11 | Grant | 19,346 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-08-11 | Tax withheld | 9,592 | $18.91 | 181,385 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-05-15 | Sell | 21,401 | $34.55 | 739,405 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-03-15 | Tax withheld | 7,330 | $30.65 | 224,664 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-03-09 | Sell | 18,496 | $31.59 | 584,289 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2023-01-31 | Grant | 43,774 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2022-09-22 | Grant | 42,349 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2022-09-14 | Sell | 11,000 | $27.07 | 297,770 |
| showing 20 of 32 most recent transactions | |||||